Homebiopharmaceutical

biopharmaceutical

AzurRx BioPharma Announces First Patients Dosed in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

AzurRx BioPharma Announces First Patients Dosed in Turkey for Phase 2 Combination Therapy Trial of MS1819 in Cystic Fibrosis Patients with Severe Exocrine Pancreatic Insufficiency

November 30, 2020

Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

Corvus Announces Upcoming CPI-818 Data Presentations at the American Society of Hematology (ASH) Annual Meeting & Exposition

November 30, 2020

Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference

Aquestive Therapeutics to Present at Piper Sandler 32nd Annual Virtual Healthcare Conference

November 25, 2020

Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

Eiger BioPharmaceuticals Announces FDA Approval of Zokinvy(TM) (lonafarnib): The First Treatment for Hutchinson-Gilford Progeria Syndrome and Processing-Deficient Progeroid Laminopathies

November 25, 2020

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

ESSA Pharma to Participate at Evercore ISI 3rd Annual HealthCONx Conference

November 25, 2020

Eiger (EIGR) Gets FDA Approval for Zokinvyin Rare Diseases

Eiger (EIGR) Gets FDA Approval for Zokinvyin Rare Diseases

November 24, 2020

Here’s Why Momentum Investors Will Love CorMedix (CRMD)

Here’s Why Momentum Investors Will Love CorMedix (CRMD)

November 24, 2020

Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States

Eton Pharmaceuticals Announces Availability of Orphan Drug ALKINDI® SPRINKLE (hydrocortisone) in the United States

November 24, 2020

InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein

InvestorBrandNetwork (IBN) Announces Latest Episode of Stock2Me Podcast Featuring AzurRx Biopharma Inc. President & CEO James Sapirstein

November 24, 2020

Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19

Capricor Therapeutics Commences Dosing Patients in Phase 2 Trial of CAP-1002 in Patients with Severe COVID-19

November 24, 2020

« 1 … 555 556 557 558 »